Skip to main content

Microneedle-mediated SARS-CoV-2 DNA Vaccine

Award type :
Product Development Award
Product type :
Vaccines
Award year :
2020
Project start date :
07 / 20 / 2020
Project end date :
07 / 31 / 2021
Project duration (months) :
12
Development stage :
Preclinical
Target disease :
COVID-19
Region served :
World
Recipient organization / Country of funding recipient organization :
QuadMedicine / Republic of Korea
Collaborator(s) / Country :
Gachon University / Republic of Korea
Funding amount(KRW) :
400,000,000

This project is led by QuadMedicine and Gachon University and aims to develop a COVID-19 Microneedle Array Patch (MAP) for use in low- and middle income countries to administer DNA/RNA vaccines. It overcomes the limitations of conventional electroporation methods in the delivery of nucleic acid vaccines.